A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...
MUMBAI, May 20 (Reuters) - The U.S. Food and Drug Administration has approved Lupin Ltd's anti-bacterial levofloxacin tablets in multiple strengths, according to the regulator's website. (Reporting by ...
BAUDETTE, Minn., March 27, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANIP) today announced the launch of Levofloxacin Oral Solution, a generic version of the Reference Listed Drug (RLD) ...